SCHEMBL6405854

SCHEMBL6405854

Cc1ccc([N+](=O)[O-])cc1CCC(N)=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.50
TDP1 Q9NUW8 3/20 0.50
TSHR P16473 3/20 0.50
CYP3A4 P08684 3/20 0.50
LMNA P02545 2/20 0.47
MAPT P10636 2/20 0.44
PDE2A O00408 1/20 0.43
PDE5A O76074 1/20 0.43
ALOX15 P16050 1/20 0.43
NFKB1 P19838 1/20 0.43
APEX1 P27695 1/20 0.43
PDE4A P27815 1/20 0.43
BLM P54132 1/20 0.43
PDE1B Q01064 1/20 0.43
PMP22 Q01453 1/20 0.43
PDE4B Q07343 1/20 0.43
PDE4D Q08499 1/20 0.43
PDE7A Q13946 1/20 0.43
PDE1C Q14123 1/20 0.43
PDE7B Q9NP56 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28854014 0.93 CYP3A4 (0.49) ALDH1A1TDP1TSHRCYP3A4LMNA
SCHEMBL4658055 0.91 CYP3A4 (0.47) ALDH1A1TDP1TSHRCYP3A4LMNA
SCHEMBL28290292 0.86 NPSR1 (0.56) ALDH1A1TDP1TSHRCYP3A4LMNA
SCHEMBL13723969 0.84 TDP1 (0.49) ALDH1A1TDP1TSHRCYP3A4MAPT
SCHEMBL28040672 0.84 ALDH1A1 (0.53) ALDH1A1TDP1TSHRCYP3A4LMNA
SCHEMBL13268485 0.82 ALDH1A1 (0.47) ALDH1A1TDP1TSHRCYP3A4LMNA
SCHEMBL28747080 0.82 KMT2A (0.53) ALDH1A1LMNAMAPTKMT2AHTT
SCHEMBL16975448 0.81 ALDH1A1 (0.56) ALDH1A1TDP1TSHRCYP3A4LMNA
SCHEMBL5106226 0.80 LMNA (0.46) ALDH1A1TDP1TSHRCYP3A4LMNA
SCHEMBL10340437 0.79 ALDH1A1 (0.58) ALDH1A1TDP1TSHRCYP3A4LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof AGRIUS GROUP, LLC. 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof ABCG2, ATP5ME, DNTT ALDH1A1 720/4885TDP1 288/4885TSHR 3470/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.